BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories. BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories.
BIOQUAL: 2014 2013 Revenue $ 21,579,740 $ 20,204,308...
BIOQUAL, Inc. (BIOQUAL), announced today that it has completed its acquisition of ABL, Inc.’s (ABL) in-vivo animal model services-related assets. BIOQUAL and ABL will jointly market...
ABL, Inc. (ABL), and BIOQUAL, Inc. (BIOQUAL) announced today that they have signed a definitive agreement for BIOQUAL to acquire in-vivo animal model services-related assets from ABL. The...
BIOQUAL, Inc. (Pinksheets: BIOQ): 2013 2012 Revenue $ 20,204,308 $ 22,667,149...
Dr. John C. Landon founded BIOQUAL in 1982. He led BIOQUAL for more than 30 years as President and Chief Executive Officer, and grew BIOQUAL to its current position as a $20M+ life sciences...
BIOQUAL (Pinksheets: BIOQ): 2012 2011 Revenue $ 22,667,149...
BIOQUAL (Pinksheets: BIOQ) has received notice from the National Cancer Institute (NCI) that the NCI will not be exercising its option to renew the contract “Facility for...
Dr. Mark Lewis has been promoted to President of BIOQUAL Inc. (Pinksheets: BIOQ) by the Board of Directors effective November 15, 2010. Dr. John Landon will continue as Chief...
BIOQUAL (Pinksheets:BIOQ): 2010 2009...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.5 | -3.57142857143 | 70 | 70 | 67.5 | 500 | 67.875 | CS |
4 | -2.5 | -3.57142857143 | 70 | 70 | 67.5 | 383 | 68.15217391 | CS |
12 | -5 | -6.89655172414 | 72.5 | 72.5 | 67.5 | 334 | 69.79962547 | CS |
26 | -9.5 | -12.3376623377 | 77 | 77 | 67.5 | 333 | 71.29554222 | CS |
52 | 7.5 | 12.5 | 60 | 80 | 59 | 313 | 70.97420174 | CS |
156 | -17 | -20.1183431953 | 84.5 | 108.5 | 57 | 477 | 78.16317146 | CS |
260 | 33.5 | 98.5294117647 | 34 | 108.5 | 34 | 546 | 66.58832746 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales